Contribution of apoe genetic variants to dyslipidemia

نویسندگان

چکیده

Background and Aims : To identify common rare genetic variants in APOE gene a cohort of subjects with primary hyperlipidemia compare them general population.Methods: A total 3180 unrelated consecutive were recruited the Lipid Unit at Hospital Universitario Miguel Servet, Zaragoza, Spain. Patients divided according to their lipid phenotype. 1426 patients diagnosed isolated hypercholesterolemia if triglycerides (TG) <200 mg/dL + LDL cholesterol (LDLc) ≥160 or apo B ≥120 mg/dL; 1515 mixed when TG ≥200 non-HDLc ≥190 239 hypertriglyceridemia TG≥200 <190 <120 376 considered normolipemic (TG LDLc <160 mg/dL). We also studied 822 random from Aragon Workers Health Study (AWHS), longitudinal study cardiovascular risk factors subclinical atherosclerosis, as population. In all subjects, exon 4 was sequenced clinical analytical variables registered.Conclusions: Ten different identified 30 hyperlipidemias, that not found controls neither AWHS cohort, suggesting they could be causally associated abnormalities. summary, our results suggest variability contributes etiology dyslipidemias, only dysbetalipoproteinemia. Methods: registered. Conclusions:

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Association of genetic variants with dyslipidemia.

Although genetic variants, which regulate lipid metabolism, have been extensively investigated in Caucasian populations, the genes, which confer susceptibility to dyslipidemia in Japanese individuals, remain to be elucidated. The aim of the present study was to examine a possible association among hypertriglyceridemia, hypo‑high density lipoprotein (HDL)‑cholesterolemia or hyper‑low density lip...

متن کامل

Genetic Contribution of Variants near SORT1 and APOE on LDL Cholesterol Independent of Obesity in Children

OBJECTIVE To assess potential effects of variants in six lipid modulating genes (SORT1, HMGCR, MLXIPL, FADS2, APOE and MAFB) on early development of dyslipidemia independent of the degree of obesity in children, we investigated their association with total (TC), low density lipoprotein (LDL-C), high density lipoprotein (HDL-C) cholesterol and triglyceride (TG) levels in 594 children. Furthermor...

متن کامل

Contribution of Regulatory and Structural Variations in the APOE Gene to Predicting Dyslipidemia

National Public Health Institute, Helsinki, Finland; Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA; Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA; Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Human Genetics Center and Institute of Molecular Medicine, The University of Texas Health Sc...

متن کامل

Contribution of regulatory and structural variations in APOE to predicting dyslipidemia.

The objective of this study was to evaluate 1) whether non single nucleotide polymorphisms-coding (non-cSNP) in the apolipoprotein E gene (APOE) identified by resequencing studies contribute to statistically explaining dyslipidemia if variations in the two cSNPs in exon 4 that define the 2, 3, and 4 alleles are ignored, and 2) whether the contribution of these additional SNPs persists when vari...

متن کامل

Aspirin resistance with genetic dyslipidemia: contribution of vascular thromboxane generation.

One clinical intervention against the negative outcomes associated with atherothrombotic vascular disease (AVD) is low-dose, chronic aspirin therapy. However, epidemiological studies suggest that recurrence of adverse vascular events with aspirin therapy is growing and associated with therapy duration. The contributors to this outcome are unclear and include poor patient compliance and aspirin-...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Atherosclerosis

سال: 2022

ISSN: ['0021-9150', '1879-1484']

DOI: https://doi.org/10.1016/j.atherosclerosis.2022.06.733